These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 10766148

  • 1. Complications of systemic chemotherapy as treatment of retinoblastoma.
    Benz MS, Scott IU, Murray TG, Kramer D, Toledano S.
    Arch Ophthalmol; 2000 Apr; 118(4):577-8. PubMed ID: 10766148
    [No Abstract] [Full Text] [Related]

  • 2. Multifaceted chemotherapy for trilateral retinoblastoma.
    Dimaras H, Héon E, Doyle J, Strahlendorf C, Paton KE, Halliday W, Babyn P, Gallie BL, Chan HS.
    Arch Ophthalmol; 2011 Mar; 129(3):362-5. PubMed ID: 21402997
    [No Abstract] [Full Text] [Related]

  • 3. Lack of vincristine infiltrates in patients with retinoblastoma receiving chemotherapy by peripheral intravenous lines.
    DiDomenico C, Clerico D, Leahey A.
    Pediatr Blood Cancer; 2015 Oct; 62(10):1859-61. PubMed ID: 25929686
    [Abstract] [Full Text] [Related]

  • 4. Randomized, controlled trial in groups C and D retinoblastoma.
    Meel R, Bakhshi S, Pushker N, Vishnubhatla S.
    Ophthalmology; 2015 Feb; 122(2):433-5. PubMed ID: 25439612
    [No Abstract] [Full Text] [Related]

  • 5. Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study.
    Chawla B, Hasan F, Seth R, Pathy S, Pattebahadur R, Sharma S, Upadhyaya A, Azad R.
    Ophthalmology; 2016 Sep; 123(9):1933-9. PubMed ID: 27449712
    [Abstract] [Full Text] [Related]

  • 6. A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy.
    Lambert MP, Shields C, Meadows AT.
    Pediatr Blood Cancer; 2008 Feb; 50(2):223-6. PubMed ID: 17278120
    [Abstract] [Full Text] [Related]

  • 7. Diffuse infiltrating retinoblastoma with central nervous system metastasis.
    Khetan V, Al-Kharusi N, Ganesh A, Al-Futaisi A, Biswas J, Kumar K, Raja T.
    Arch Ophthalmol; 2011 Mar; 129(3):375-7. PubMed ID: 21403001
    [No Abstract] [Full Text] [Related]

  • 8. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP, Honavar SG, Reddy VA, Khanna R.
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [Abstract] [Full Text] [Related]

  • 9. What is the best treatment for retinoblastoma?
    Harbour JW.
    Am J Ophthalmol; 2004 Sep; 138(3):471-3. PubMed ID: 15364232
    [No Abstract] [Full Text] [Related]

  • 10. Residual intraretinal retinoblastoma after chemoreduction failure.
    Hwang CK, Aaberg TM, Chevez-Barrios P, Verner-Cole E, Gombos DS, Paysse E, Chintagumpala M, Gao W, Grossniklaus HE.
    Arch Ophthalmol; 2012 Feb; 130(2):246-8. PubMed ID: 22332223
    [No Abstract] [Full Text] [Related]

  • 11. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
    Künkele A, Wilm J, Holdt M, Lohmann D, Bornfeld N, Eggert A, Temming P, Schulte JH.
    Br J Ophthalmol; 2015 Jul; 99(7):949-53. PubMed ID: 25583279
    [Abstract] [Full Text] [Related]

  • 12. Superselective intra-arterial chemotherapy for advanced retinoblastoma complicated by metastatic disease.
    Mathew AA, Sachdev N, Staffieri SE, McKenzie JD, Elder JE.
    J AAPOS; 2015 Feb; 19(1):72-4. PubMed ID: 25727592
    [Abstract] [Full Text] [Related]

  • 13. Retinoma underlying retinoblastoma revealed after tumor response to 1 cycle of chemotherapy.
    Dimaras H, Khetan V, Halliday W, Héon E, Chan HS, Gallie BL.
    Arch Ophthalmol; 2009 Aug; 127(8):1066-8. PubMed ID: 19667353
    [No Abstract] [Full Text] [Related]

  • 14. New retinoblastoma tumors in children undergoing systemic chemotherapy.
    Scott IU, Murray TG, Toledano S, O'Brien JM.
    Arch Ophthalmol; 1998 Dec; 116(12):1685-6. PubMed ID: 9869808
    [No Abstract] [Full Text] [Related]

  • 15. A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231).
    Jubran RF, Villablanca JG, Krailo M, Piao J, Huang L, Murphree AL, O'Brien J, Gombos D, Shields CL, Meadows A, Chintagumpala M.
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28502. PubMed ID: 32589362
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.